Robert Rosen - Net Worth and Insider Trading

Robert Rosen Net Worth

The estimated net worth of Robert Rosen is at least $3,379 dollars as of 2024-11-13. Robert Rosen is the President of Heron Therapeutics Inc and owns about 2,640 shares of Heron Therapeutics Inc (HRTX) stock worth over $3,379. Details can be seen in Robert Rosen's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Rosen has not made any transactions after 2018-07-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Robert Rosen

To

Robert Rosen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Rosen owns 5 companies in total, including La Jolla Pharmaceutical Co (LJPC) , Odonate Inc (ODTC) , and Heron Therapeutics Inc (HRTX) among others .

Click here to see the complete history of Robert Rosen’s form 4 insider trades.

Insider Ownership Summary of Robert Rosen

Ticker Comapny Transaction Date Type of Owner
LJPC La Jolla Pharmaceutical Co 2022-08-22 director
ODTC Odonate Inc 2017-12-06 director
HRTX Heron Therapeutics Inc 2018-07-02 director
LIMIT LIMIT 2015-07-27 director
LIMIT LIMIT 2015-07-27 director

Robert Rosen Latest Holdings Summary

Robert Rosen currently owns a total of 1 stock. Robert Rosen owns 2,640 shares of Heron Therapeutics Inc (HRTX) as of July 2, 2018, with a value of $3,379.

Latest Holdings of Robert Rosen

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
HRTX Heron Therapeutics Inc 2018-07-02 2,640 1.28 3,379

Holding Weightings of Robert Rosen


Robert Rosen Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Rosen has made a total of 0 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years. The most-recent trade in Heron Therapeutics Inc is the sale of 225,000 shares on July 2, 2018, which brought Robert Rosen around $9 Million.

Insider Trading History of Robert Rosen

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Rosen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Robert Rosen Ownership Network

Ownership Network List of Robert Rosen

No Data

Ownership Network Relation of Robert Rosen

Insider Network Chart

Robert Rosen Owned Company Details

What does La Jolla Pharmaceutical Co do?

Who are the key executives at La Jolla Pharmaceutical Co?

Robert Rosen is the director of La Jolla Pharmaceutical Co. Other key executives at La Jolla Pharmaceutical Co include director & 10 percent owner Kevin C Tang , director & Chief Executive Officer Larry G. Edwards , and Chief Financial Officer Michael S Hearne .

La Jolla Pharmaceutical Co (LJPC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of La Jolla Pharmaceutical Co (LJPC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of La Jolla Pharmaceutical Co (LJPC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

La Jolla Pharmaceutical Co (LJPC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

La Jolla Pharmaceutical Co Insider Transactions

No Available Data

Robert Rosen Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Rosen. You might contact Robert Rosen via mailing address: C/o Heron Therapeutics, Inc, 4242 Campus Point Court, Suite 200, San Diego Ca 92121.